support@custommarketinsights.com+1 737 734 2707
  1. Home
  2. Clinical Diagnostics
  3. Ultrasound AI Market

Ultrasound AI Market 2026-2035

Market size, share and growth analysis by component, application, deployment and end user, across all major regions and key countries, with forecasts for 2026–2035. The competitive landscape profiles 8+ companies.

  • Updated:
  • Report ID:93078
  • Author:Ayush Kadam
  • 220+ Pages
  • 8+ Companies
  • 51+ Tables
  • 29+ Charts
  • Base year 2025
  • Forecast 2026-2035
  • Global coverage
USD 2.55 Bn
Market size, 2026
USD 15.27 Bn
Forecast, 2035
22%
CAGR, 2026-2035
North America
Largest region
Asia Pacific
Fastest-growing region

The global ultrasound AI market was valued at USD 2.55 Bn in 2026 and is projected to reach USD 15.27 Bn by 2035, growing at a CAGR of 22%. North America is the largest regional market and Asia Pacific is growing fastest.

Report Description

The global ultrasound AI market size was estimated at USD 2.09 billion in 2025 and will grow with a CAGR of 22% from 2026 to 2035, reaching USD 15.27 billion by 2035.


North America has the largest share of the market, accounting for around 38% in 2025, owing to early regulatory clearance of AI-enabled ultrasound software, strong hospital and imaging center investment in diagnostic automation, and the concentration of leading medical imaging and AI software developers in the region.

Growth here is driven less by imaging hardware than by what the software attached to it can now do. Ultrasound has always been the cheapest and most portable of the major imaging modalities and also the most operator-dependent. AI is closing that gap, and in doing so it is turning ultrasound from a specialist procedure into something a much wider group of clinicians can perform reliably.

Market Highlight

  • In 2025, the software segment accounted for the largest component share, reflecting continued demand for AI algorithms that automate image acquisition guidance, measurement, and interpretation. Vendors increasingly sell these capabilities on subscription rather than as a one-time license, which gives the segment a recurring revenue profile that hardware sales do not have.
  • Radiology remained the leading application segment, while obstetrics & gynecology is expected to register the fastest growth as AI-assisted fetal biometry and anomaly detection tools gain clinical adoption. Automated gestational age estimation has drawn particular attention because it works from simple probe sweeps, allowing dating scans in clinics with no sonographer on staff.
  • Point-of-care and handheld ultrasound devices integrated with AI are the fastest-growing deployment category, extending diagnostic-quality imaging capability to emergency departments, primary care, and remote settings. Falling probe prices matter here, but so does bundling. Several manufacturers now ship AI guidance with the device rather than selling it as an optional add-on. Training requirements fall sharply as a result, and several health systems now credential general clinicians for defined scan types rather than sending every request to a sonographer.
  • Hospitals represented the largest end-user segment, driven by high patient volumes and the operational value of AI in reducing scan time and operator dependency. Large systems also have the IT infrastructure needed to route ultrasound AI outputs into electronic health records, which is often what determines whether a deployment spreads beyond a single department.
  • North America dominated the ultrasound AI market in 2025, while Asia Pacific is expected to register the fastest growth through 2035 as healthcare expenditure rises and point-of-care ultrasound adoption accelerates across the region. Rural access gaps and a thin supply of trained sonographers give AI guidance more practical value there than in markets that already have deep imaging staffing.

Significant Growth Factors

The ultrasound AI market trends present significant growth opportunities due to several factors. Adoption is being pulled forward by workforce pressure as much as by technology enthusiasm, and the two developments below account for most of the demand vendors are currently reporting:

  • Addressing the Global Sonographer Shortage Through Automation: A persistent global shortage of trained sonographers, combined with rising demand for diagnostic imaging as chronic disease prevalence increases, has created strong clinical and commercial incentives for AI tools that reduce operator dependency by guiding probe positioning, automating standard-plane image acquisition, and performing automated measurements that previously required extensive manual expertise. These capabilities are particularly valuable in primary care and emergency settings where dedicated sonographers are frequently unavailable, allowing a broader range of clinicians to perform diagnostic-quality point-of-care scans with AI-guided support. Health systems facing long imaging backlogs and persistent staff turnover are increasingly evaluating these tools as a workforce strategy rather than a purely technical upgrade, expanding the addressable base of ultrasound users well beyond traditional radiology and cardiology departments.
  • Integration With Portable and Handheld Ultrasound Devices: The rapid commercial expansion of compact, smartphone-connected handheld ultrasound probes has created a natural and highly complementary growth pathway for AI software, since these devices depend heavily on automated image optimization and interpretation assistance to be usable by clinicians without extensive sonography training. As handheld device costs continue to decline and image quality improves, AI-enabled point-of-care ultrasound is increasingly being adopted in ambulances, rural clinics, military and disaster-response settings, and outpatient practices where traditional cart-based systems were previously impractical. Device manufacturers are also bundling AI subscriptions with hardware sales, creating recurring software revenue streams that improve category economics and significantly broaden the settings in which ultrasound AI can be deployed and monetized.

Drivers Impact Analysis

Impact Factor

Estimated CAGR Impact

Regional Relevance

Market Impact

Global shortage of trained sonographers and radiologists

+5.8%

Global

Drives demand for automated imaging support

Rapid growth of portable and handheld ultrasound devices

+4.6%

North America, Asia Pacific

Expands point-of-care AI deployment

Rising prevalence of chronic diseases requiring imaging follow-up

+3.5%

Global

Increases overall ultrasound scan volume

Expanding regulatory clearance of AI-enabled imaging software

+2.8%

North America, Europe

Accelerates clinical adoption and reimbursement

Growing hospital investment in diagnostic workflow automation

+2.1%

North America, Asia Pacific

Supports enterprise-wide software deployment

Restraints Impact Analysis

Impact Factor

Estimated CAGR Impact

Regional Relevance

Market Impact

High cost of AI-integrated ultrasound systems and software licensing

-2.6%

Asia Pacific, Latin America

Limits adoption among smaller facilities

Regulatory complexity and lengthy approval pathways

-2.0%

Global

Slows time to market for new algorithms

Clinician trust and validation concerns for AI-assisted diagnosis

-1.5%

Global

Slows full clinical workflow integration

Data privacy and interoperability challenges

-1.1%

Europe, North America

Complicates enterprise-wide software deployment

Limited reimbursement pathways for AI-assisted imaging services

-0.9%

Asia Pacific, Latin America

Restricts return on investment for buyers

What are the Major Advances Changing the Ultrasound AI Market Today?

  • Automated Image Acquisition Guidance: AI systems that provide real-time, on-screen guidance to help operators achieve standard diagnostic imaging planes have matured significantly, reducing the training threshold required to obtain clinically usable scans and directly addressing one of the most persistent barriers to expanding point-of-care ultrasound use among non-specialist clinicians. These systems typically combine live probe-position prompts, automatic image quality scoring, and auto-capture of the best available frame so that diagnostic quality depends far less on the individual operator’s experience. They are increasingly bundled directly into handheld device software rather than sold separately, effectively enabling entry-level clinical staff to perform common diagnostic applications such as cardiac function, lung, and bladder assessment.
  • AI-Assisted Quantitative Measurement and Reporting: Automated measurement tools that calculate cardiac ejection fraction, fetal biometry, and organ dimensions directly from captured images are reducing both scan time and inter-operator measurement variability, improving diagnostic consistency across different clinicians and facilities. Because these values are generated through a defined algorithmic process rather than manual caliper placement, repeat studies become considerably more comparable over time, which matters in longitudinal monitoring of chronic cardiac, hepatic, and obstetric conditions. Several vendors are extending these tools toward automated draft report generation and structured data export into electronic health record systems, further reducing administrative burden on radiologists and sonographers and improving departmental throughput without additional staffing.
  • Expansion Into Early Disease Detection and Risk Stratification: Beyond image acquisition and measurement support, newer AI algorithms are being developed to identify subtle imaging patterns associated with early-stage disease, such as liver fibrosis, thyroid nodule malignancy risk, or subclinical cardiac dysfunction, that may be difficult for the human eye to consistently detect. These models are typically trained on large multi-site image libraries and validated against biopsy, laboratory, or advanced imaging reference standards, which is gradually improving clinician confidence in their outputs. Positioning ultrasound AI as a screening and risk-stratification tool rather than only a workflow aid opens materially larger clinical use cases in chronic disease monitoring programs where ultrasound is already the most accessible imaging modality.

Category Wise Insights

By Component

Why Does Software Lead the Market?

Software held the largest component share in 2025, as AI algorithms for image acquisition guidance, automated measurement, and diagnostic interpretation assistance represent the core value proposition of ultrasound AI. Recurring licensing and subscription models further strengthen software revenue, while services such as installation, integration, and clinical training remain a smaller and largely complementary revenue stream.

By Application

Why Does Radiology Lead the Market?

Radiology led application demand, as it represents the largest overall volume of diagnostic ultrasound procedures performed globally, spanning abdominal, vascular, and small-bowel imaging. AI tools that improve reading efficiency, standardize measurements, and support consistent structured reporting deliver substantial operational value in high-throughput radiology departments facing persistent staffing shortages and reporting backlogs.

By Deployment

Why Is Handheld / Point-of-Care the Fastest-Growing Deployment?

Handheld and point-of-care deployment is growing fastest as compact, AI-enabled ultrasound probes extend diagnostic imaging capability into emergency departments, primary care clinics, ambulances, and remote settings that previously lacked dedicated sonography expertise. Lower hardware costs and bundled AI subscriptions make these systems accessible to facilities that could not justify traditional cart-based equipment investment.

By End User

Why Do Hospitals Lead the Market?

Hospitals represented the largest end-user segment, as high patient imaging volumes and complex case mixes make the operational efficiency gains from AI, including reduced scan time and lower operator dependency, particularly valuable in large, high-throughput clinical settings. Established enterprise imaging infrastructure and dedicated capital budgets also make hospitals the most straightforward environment for department-wide AI deployment.

To learn more about this report - request a sample report PDF

Report Scope
Feature of the Report Details
Market Size in 2026 USD 2.55 billion
Projected Market Size in 2035 USD 15.27 billion
Market Size in 2025 USD 2.09 billion
CAGR Growth Rate 22% CAGR
Base Year 2025
Forecast Period 2026-2035
Key Segment By Component, Application, Deployment, End User and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Regional Analysis

How Big is the North America Market Size?

The North America ultrasound AI market size is forecast to reach USD 0.79 billion in 2025 and is expected to reach around USD 5.34 billion by 2035, registering a CAGR of 21.0% from 2026 to 2035. Growth is supported by a large installed base of ultrasound systems, early adoption of AI-enabled imaging software across hospital networks, and sustained provider investment in diagnostic workflow automation.


To learn more about this report - request a sample report PDF

Why Did North America Dominate the Market in 2025?

North America accounted for around 38% of the market in 2025, supported by early regulatory clearance of AI-enabled ultrasound software, strong hospital and imaging center investment in diagnostic automation, and the concentration of leading medical imaging and AI software developers in the United States. Established reimbursement pathways for diagnostic imaging and an acute regional sonographer shortage further reinforced adoption.

Why is Europe a Strategically Important Market?

Europe represents a significant and growing market, supported by strong public healthcare system investment in diagnostic imaging modernization and a well-established regulatory framework that has enabled relatively efficient approval of AI-enabled medical imaging software. Expanding use of point-of-care ultrasound across primary and emergency care in Germany, France, and the United Kingdom is further widening the clinical base for AI-assisted scanning.

Why is Asia Pacific the Fastest-Growing Region?

Asia Pacific is expected to grow fastest through 2035 as rising healthcare expenditure, expanding hospital infrastructure, and rapid adoption of point-of-care ultrasound across China, Japan, South Korea, and India accelerate demand for AI-assisted diagnostic imaging tools. Large underserved rural populations and limited specialist radiology capacity make automated image guidance especially valuable, while domestic manufacturers increasingly bundle AI features into affordable systems.

Key Market Players

  • Koninklijke Philips N.V.
  • GE Healthcare
  • Siemens Healthineers AG
  • Canon Medical Systems Corporation
  • Samsung Medison Co. Ltd.
  • Butterfly Network Inc.
  • Caption Health Inc.
  • Exo Imaging Inc.
  • Others

Key Developments

The market has seen rapid regulatory and commercial activity as GE HealthCare, Philips, and Butterfly Network expand AI capabilities across cart-based and handheld ultrasound platforms.

  • March 2026 — Butterfly Network, Inc. (NYSE: BFLY) received FDA clearance for a fully automated Gestational Age Tool on its handheld platform, reported as the first cleared AI blind-sweep solution for estimating gestational age, enabling non-specialist providers to date a pregnancy in under two minutes without manual fetal biometry. (Source: HLTH — https://hlth.com/insights/news/butterfly-network-wins-fda-clearance-for-ai-ultrasound-tool-in-women-s-health-2026-03-31)
  • February 2026 — GE HealthCare expanded its collaboration with the U.S. Biomedical Advanced Research and Development Authority (BARDA) by approximately USD 35 million to develop AI-powered point-of-care ultrasound tools for lung pathology and intra-abdominal injury assessment in emergency and field settings, explicitly targeting reduced operator dependency for non-expert users. (Source: DOTmed — https://www.dotmed.com/news/story/66051)
  • June–July 2026 — Koninklijke Philips N.V. received FDA 510(k) clearance for Elevate Plus, extending AI automation such as Auto Measure Abdomen and on-cart Koios decision support to its EPIQ Elite and Affiniti systems to standardise routine exams and reduce repeat scanning, and subsequently launched the Alturion ultrasound system with AI-powered workflow for high-volume clinical environments. (Sources: MassDevice — https://www.massdevice.com/philips-fda-clearance-elevate-ai-ultrasound/; Philips — https://www.philips.com/a-w/about/news/archive/standard/news/press/2026/philips-introduces-alturion-ultrasound-system-with-ai-powered-workflows-for-high-volume-clinical-environments.html)

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America
Rate this report

Ultrasound AI Market 2026-2035

Updated: November 2026 · Formats: PDF, Excel, PPT

Frequently asked questions

What is the Ultrasound AI Market size?

The global ultrasound AI market has been estimated at USD 2.09 billion in 2025 and is expected to reach USD 15.27 billion by 2035, growing at a CAGR of 22.0% from 2026 to 2035. That is roughly a sevenfold increase over the decade, one of the steeper growth curves anywhere in medical imaging. The figure covers AI software and associated services sold for use with cart-based and handheld ultrasound systems and excludes revenue from the ultrasound hardware itself. Growth is also front-loaded toward software rather than services, so the revenue mix shifts steadily over the forecast window.

What are the primary uses of ultrasound AI?

Ultrasound AI is used mainly to guide image acquisition, automate diagnostic measurements, assist in image interpretation, and extend usable diagnostic ultrasound capability to clinicians without extensive sonography training. In practice a single product often does several of these at once. A cardiac tool might prompt the operator to reposition the probe, capture the best frame automatically, calculate ejection fraction from it, and push the result into the patient record without anyone typing a number. Triage is an emerging fifth use. Some tools now flag studies that need urgent review, which changes the order in which a radiologist works through a list rather than what they see in any individual scan.

Which component dominates the market?

Software held the largest component share in 2025, driven by demand for AI algorithms that automate image guidance, measurement, and interpretation. Services such as installation, integration with hospital IT systems, and clinical training make up the remainder. Services revenue tends to spike around new deployments and then taper, whereas software licenses renew annually, so the gap between the two is expected to widen rather than narrow. Pricing models vary widely, from per-device subscriptions to per-study fees, and there is no settled industry standard yet. Buyers increasingly negotiate enterprise agreements covering multiple departments, which favours vendors able to support cardiology, obstetrics, and general imaging from one platform.

Which region leads the ultrasound AI market?

North America led the market in 2025 with around 38% share, supported by early regulatory clearances and strong hospital investment in diagnostic automation. The United States accounts for most of that. A large installed base of ultrasound systems, established reimbursement for diagnostic imaging, and a well-documented shortage of sonographers have pushed health systems to treat AI as a staffing solution rather than only a technical upgrade. Canada contributes a smaller but steadily growing share, driven mainly by provincial investment in rural imaging access rather than by hospital capital spending.

What is the projected market size by 2035?

Continued sonographer shortages, expanding point-of-care device adoption, and rising chronic disease prevalence are expected to push the market to approximately USD 15.27 billion by 2035. Two things could move that number. Broader reimbursement for AI-assisted imaging would accelerate it, since smaller facilities currently struggle to demonstrate a return. Slower regulatory throughput, or a serious clinical failure that damages physician trust, would work the other way. Handheld device penetration is the variable most worth watching, since every probe sold is a potential software subscription attached to it.

How does AI improve ultrasound diagnostic accuracy?

AI tools reduce inter-operator variability by standardizing image acquisition and measurement processes and can help identify subtle imaging patterns associated with early-stage disease that may be difficult to consistently detect through manual review alone. The consistency benefit is arguably the more important one day to day. When the same patient is scanned by three different technologists over a year, algorithmic measurement makes those studies comparable in a way manual caliper placement rarely does. Validation remains the sticking point. Performance measured on a vendor’s own dataset does not always survive contact with a different patient population or an older machine.

Who are the key players in the Ultrasound AI market?

The key players in the market are Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers AG, Canon Medical Systems Corporation, Samsung Medison Co. Ltd., Butterfly Network Inc., Caption Health Inc., and Exo Imaging Inc.

Meet the team

Ayush Kadam

Ayush Kadam

Author · Sr. Research Analyst

Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.

Shraddha Wankhade

Shraddha Wankhade

Reviewed By · Lead Consultant

Shraddha Wankhade is a Lead Consultant at Custom Market Insights, specializing in market research, business consulting, competitive intelligence, and strategic advisory. She delivers customized research and actionable insights that help organizations identify opportunities, make informed decisions, and achieve sustainable business growth.

More Clinical Diagnostics reports

Free sampleBuy report

Free sample

Get the sample report

Ultrasound AI Market: sample pages and table of contents by email.

Security codeCode didn’t load.

We use these details only to answer this request. Privacy policy